Prior to publication of the final evidence report, EPCs sought input from independent Peer Reviewers without financial conflicts of interest. However, the conclusions and synthesis of the scientific literature presented in this report do not necessarily represent the views of individual reviewers.
Peer Reviewers must disclose any financial conflicts of interest greater than $10,000 and any other relevant business or professional conflicts of interest. Because of their unique clinical or content expertise, individuals with potential nonfinancial conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any potential nonfinancial conflicts of interest identified.
The list of Peer Reviewers follows:
- Mary Ann Forciea, M.D.Medical CenterUniversity of PennsylvaniaPhiladelphia, PA
- Angela B. Smith, M.D., M.S.Department of UrologyLineberger Comprehensive Cancer CenterUniversity of North CarolinaChapel Hill, NC
Publication Details
Copyright
Publisher
Agency for Healthcare Research and Quality (US), Rockville (MD)
NLM Citation
Brasure M, MacDonald R, Dahm P, et al. Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostaic Hyperplasia: A Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May. (Comparative Effectiveness Reviews, No. 178.) Peer Reviewers.